Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action in portal system encephalopathy, Drugs, 4, 7-48 (1972). J. Tomlin and N. W. Read, The relation between bacterial degradation of viscous polysaccharides and stool output in human beings, Br. J. Nutr., 60, 467-475 (1988).

Morphine administered nasally to humans as a simple solution is only absorbed to a limited degree, with a bioavailability of the order of 10% compared with intravenous administration. This article describes the development of novel nasal morphine formulations based on chitosan, which, in the sheep model, provide a highly increased absorption with a 5-to 6-fold increase in bioavailability over simple morphine solutions. The chitosan-morphine nasal formulations have been tested in healthy volunteers in comparison with a slow i.v. infusion (over 30 min) of morphine. The results show that the nasal formulation was rapidly absorbed with a T max of 15 min or less and a bioavailability of nearly 60%. The shape of the plasma profile for nasal delivery of the chitosan-morphine formulation was similar to the one obtained for the slow i.v. administration of morphine. Furthermore, the metabolite profile obtained after the nasal administration of the chitosan-morphine nasal formulation was essentially identical to the one obtained for morphine administered by the intravenous route. The levels of both morphine-6-glucuronide and morphine-3-glucuronide were only about 25% of that found after oral administration of morphine. It is concluded that a properly designed nasal morphine formulation (such as one with chitosan) can result in a noninjectable opioid product capable of offering patients rapid and efficient pain relief.

It is concluded that chitosan derivatives offer advantageous opportunities such as nanoparticle and surface charge manipulation that facilitate vaccine targeting. Nevertheless, these technologies represent a longer-term goal. By contrast, chitosan (unmodified form) with or without a co-adjuvant has significant toxicology and human data to support safe mucosal administration, and thus has the potential for earlier product introduction into the market.

It was shown conclusively that chitosan nanoparticles did not improve the absorption enhancing effect of chitosan in solution or powder form and that chitosan powder was the most effective for mulation for nasal delivery of insulin in the sheep model.

We present a new calculation for the evolution of the 1-point Probability Distribution Function (PDF) of the cosmological density field based on an exact statistical treatment. Using the Chapman-Kolmogorov equation and second-order Eulerian perturbation theory we propagate the initial density distribution into the nonlinear regime. Our calculations yield the moment generating function, allowing a straightforward derivation of the skewness of the PDF to second order. We find a new dependency on the initial perturbation spectrum. We compare our results with other approximations to the 1-pt PDF, and with N-body simulations. We find that our distribution accurately models the evolution of the 1-pt PDF of dark matter.Comment: 7 pages, 7 figures, accepted for publication in MNRA